Xuedong Lv

471 total citations
23 papers, 339 citations indexed

About

Xuedong Lv is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Xuedong Lv has authored 23 papers receiving a total of 339 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 9 papers in Cancer Research and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Xuedong Lv's work include Cancer-related molecular mechanisms research (5 papers), Cancer Immunotherapy and Biomarkers (3 papers) and MicroRNA in disease regulation (3 papers). Xuedong Lv is often cited by papers focused on Cancer-related molecular mechanisms research (5 papers), Cancer Immunotherapy and Biomarkers (3 papers) and MicroRNA in disease regulation (3 papers). Xuedong Lv collaborates with scholars based in China, United Kingdom and United States. Xuedong Lv's co-authors include Hang Ma, Jinliang Chen, Jianliang Chen, Dandan Wu, Qichang Yang, Dongmei Zhang, Haiyan He, Jun Liu, Jinliang Chen and Xiao Jin and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Gene.

In The Last Decade

Xuedong Lv

23 papers receiving 337 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xuedong Lv China 12 166 108 97 72 65 23 339
You Zou China 12 182 1.1× 98 0.9× 73 0.8× 59 0.8× 34 0.5× 25 396
Veronika Holubeková Slovakia 13 241 1.5× 197 1.8× 48 0.5× 93 1.3× 81 1.2× 32 469
Xinliang Ming China 9 151 0.9× 129 1.2× 33 0.3× 52 0.7× 60 0.9× 12 286
Noemy Starita Italy 9 217 1.3× 169 1.6× 44 0.5× 87 1.2× 74 1.1× 22 452
Rui An China 9 163 1.0× 46 0.4× 36 0.4× 78 1.1× 52 0.8× 16 286
Aya El Helali Hong Kong 9 94 0.6× 53 0.5× 59 0.6× 108 1.5× 31 0.5× 34 288
Beata Biesaga Poland 12 130 0.8× 103 1.0× 114 1.2× 127 1.8× 64 1.0× 43 392
Laura Succony United Kingdom 5 118 0.7× 72 0.7× 175 1.8× 78 1.1× 17 0.3× 16 319
Yiwen Sang China 10 131 0.8× 72 0.7× 31 0.3× 67 0.9× 41 0.6× 19 278

Countries citing papers authored by Xuedong Lv

Since Specialization
Citations

This map shows the geographic impact of Xuedong Lv's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xuedong Lv with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xuedong Lv more than expected).

Fields of papers citing papers by Xuedong Lv

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xuedong Lv. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xuedong Lv. The network helps show where Xuedong Lv may publish in the future.

Co-authorship network of co-authors of Xuedong Lv

This figure shows the co-authorship network connecting the top 25 collaborators of Xuedong Lv. A scholar is included among the top collaborators of Xuedong Lv based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xuedong Lv. Xuedong Lv is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ma, Hang, et al.. (2023). Chromosomal Copy Number Variation Predicts EGFR-TKI Response and Prognosis for Patients with Non-Small Cell Lung Cancer. Pharmacogenomics and Personalized Medicine. Volume 16. 835–846. 3 indexed citations
2.
Wei, Qiong, et al.. (2023). Effect of PTGES3 on the Prognosis and Immune Regulation in Lung Adenocarcinoma. Analytical Cellular Pathology. 2023(1). 4522045–4522045. 4 indexed citations
3.
Cheng, Zhaozhong, Xuedong Lv, Chengshui Chen, et al.. (2022). Comparison of operation time, efficacy and safety between through-the-scope stent and over-the-while stent in malignant central airway obstruction: a multi-center randomized control trial. Translational Lung Cancer Research. 11(8). 1692–1701. 4 indexed citations
4.
Jin, Xiao, Juan Li, Xuedong Lv, et al.. (2022). Improving Suspected Pulmonary Infection Diagnosis by Bronchoalveolar Lavage Fluid Metagenomic Next-Generation Sequencing: a Multicenter Retrospective Study. Microbiology Spectrum. 10(4). e0247321–e0247321. 54 indexed citations
5.
Chen, Jinliang, et al.. (2022). Expression of Serum sLOX-1 in Patients with Non-Small-Cell Lung Cancer and Its Correlation with Lipid Metabolism. Canadian Respiratory Journal. 2022. 1–9. 6 indexed citations
6.
Xing, Yuanyuan, et al.. (2022). Clinical Study of Airway Stent Implantation in the Treatment of Patients with Malignant Central Airway Obstruction. Evidence-based Complementary and Alternative Medicine. 2022. 1–8. 2 indexed citations
7.
Chen, Jinliang, et al.. (2021). Clinical value of serum and exhaled breath condensate inflammatory factor IL-11 levels in non-small cell lung cancer: Clinical value of IL-11 in non-small cell lung cancer. The International Journal of Biological Markers. 36(2). 64–76. 13 indexed citations
8.
Zhou, Yilu, Liudi Yao, Charlotte Hill, et al.. (2021). GRK6 Depletion Induces HIF Activity in Lung Adenocarcinoma. Frontiers in Oncology. 11. 654812–654812. 3 indexed citations
9.
Fu, Yulong, Anqi Wang, Wei Feng, et al.. (2021). Advanced NSCLC Patients With EGFR T790M Harboring TP53 R273C or KRAS G12V Cannot Benefit From Osimertinib Based on a Clinical Multicentre Study by Tissue and Liquid Biopsy. Frontiers in Oncology. 11. 621992–621992. 14 indexed citations
10.
11.
Chen, Jinliang, et al.. (2020). Significance of vascular endothelium growth factor testing in exhaled breath condensate of patients with acute respiratory distress syndrome. Technology and Health Care. 28(1_suppl). 347–354. 3 indexed citations
12.
Chen, Jinliang, et al.. (2020). Clinical Value of Serum and Exhaled Breath Condensate miR-186 and IL-1β Levels in Non-Small Cell Lung Cancer. Technology in Cancer Research & Treatment. 19. 1079215138–1079215138. 18 indexed citations
13.
14.
15.
16.
Chen, Jinliang, et al.. (2019). Epidermal Growth Factor in Exhaled Breath Condensate as Diagnostic Method for Non-Small Cell Lung Cancer. Technology in Cancer Research & Treatment. 18. 1078139919–1078139919. 6 indexed citations
17.
Chen, Xinming, et al.. (2018). Speckle-type POZ protein functions as a tumor suppressor in non-small cell lung cancer due to DNA methylation. Cancer Cell International. 18(1). 213–213. 11 indexed citations
18.
Wu, Dandan, Jun Liu, Jianliang Chen, et al.. (2018). miR-449a Suppresses Tumor Growth, Migration, and Invasion in Non-Small Cell Lung Cancer by Targeting a HMGB1-Mediated NF-κB Signaling Pathway. Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics. 27(2). 227–235. 48 indexed citations
19.
Chen, Jinliang, et al.. (2016). Detection of cancer embryo antigen and endothelin-1 in exhaled breath condensate: A novel approach to investigate non-small cell lung cancer. Molecular and Clinical Oncology. 5(1). 124–128. 12 indexed citations
20.
Zhong, Lou, Jian Liu, Jia Feng, et al.. (2016). Prognostic value of decreased GRK6 expression in lung adenocarcinoma. Journal of Cancer Research and Clinical Oncology. 142(12). 2541–2549. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by You Zou Breakdown of academic impact, for papers by Veronika Holubeková Breakdown of academic impact, for papers by Xinliang Ming Breakdown of academic impact, for papers by Noemy Starita Breakdown of academic impact, for papers by Rui An Breakdown of academic impact, for papers by Aya El Helali Breakdown of academic impact, for papers by Beata Biesaga Breakdown of academic impact, for papers by Laura Succony Breakdown of academic impact, for papers by Yiwen Sang
Rankless by CCL
2026